Balyasny Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-90,954
| Closed | -$80.6K | – | 2863 |
|
|
2022
Q4 | $80.6K | Buy |
90,954
+54,860
| +152% | +$48.6K | ﹤0.01% | 1838 |
|
|
2022
Q3 | $57K | Sell |
36,094
-25,352
| -41% | -$40K | ﹤0.01% | 1976 |
|
|
2022
Q2 | $124K | Buy |
+61,446
| New | +$124K | ﹤0.01% | 1815 |
|
|
2022
Q1 | – | Sell |
-13,805
| Closed | -$64K | – | 2655 |
|
|
2021
Q4 | $64K | Buy |
+13,805
| New | +$64K | ﹤0.01% | 1799 |
|
|
2021
Q2 | – | Sell |
-15,266
| Closed | -$126K | – | 2223 |
|
|
2021
Q1 | $126K | Sell |
15,266
-5,864
| -28% | -$48.4K | ﹤0.01% | 1433 |
|
|
2020
Q4 | $144K | Buy |
+21,130
| New | +$144K | ﹤0.01% | 1085 |
|
|
2018
Q4 | – | Sell |
-103,252
| Closed | -$454K | – | 1655 |
|
|
2018
Q3 | $454K | Buy |
+103,252
| New | +$454K | ﹤0.01% | 1187 |
|